These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2063999)

  • 1. A case of the Rett syndrome with acute encephalopathy induced during calcium hopantenate treatment.
    Sasaki T; Minagawa M; Yamamoto T; Ichihashi H
    Brain Dev; 1991; 13(1):52-5. PubMed ID: 2063999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute encephalopathy with hyperammonemia and dicarboxylic aciduria during calcium hopantenate therapy: a patient report.
    Kimura A; Yoshida I; Ono E; Matsuishi T; Yoshino M; Yamashita F; Yamamoto M; Hashimoto T; Shinka T; Kuhara T
    Brain Dev; 1986; 8(6):601-5. PubMed ID: 3826551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary organic acids in elderly Japanese patients with ketosis and encephalopathy who have taken panto-yl-gamma-aminobutyrate, calcium salt (calcium hopantenate, HOPA).
    Nakanishi T; Funahashi S; Shimizu A; Hayashi A
    Clin Chim Acta; 1990 Apr; 188(1):85-90. PubMed ID: 2347085
    [No Abstract]   [Full Text] [Related]  

  • 4. [3 cases of acute encephalopathy associated with calcium hopantenate administration].
    Sugimoto T; Yasuhara A; Nishida N; Sakane Y; Sugimoto Y
    No To Hattatsu; 1983; 15(3):258-9. PubMed ID: 6882599
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactic acidosis with hypoglycemia and hyperammonemia observed in two uremic patients during calcium hopantenate treatment.
    Otsuka M; Akiba T; Okita Y; Tomita K; Yoshiyama N; Sasaoka T; Kanayama M; Marumo F
    Jpn J Med; 1990; 29(3):324-8. PubMed ID: 2273615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.
    Noda S; Umezaki H; Yamamoto K; Araki T; Murakami T; Ishii N
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):582-5. PubMed ID: 3379435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic acidosis and hypoglycemia during calcium hopantenate administration--report on 5 patients].
    Ohsuga S; Ohsuga H; Takeoka T; Ikeda A; Shinohara Y
    Rinsho Shinkeigaku; 1989 Jun; 29(6):741-6. PubMed ID: 2582687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
    Izumi T; Utsumi H; Osawa M; Fukuyama Y
    No To Hattatsu; 1985 Sep; 17(5):426-30. PubMed ID: 3935144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and biochemical studies in a case of acute encephalopathy associated with calcium hopanthenate administration].
    Kajita M; Iwase K; Matsumoto M; Kuhara T; Sinka T; Matsumoto I
    No To Hattatsu; 1990 May; 22(3):267-73. PubMed ID: 2194543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes.
    Matsumoto M; Kuhara T; Inoue Y; Shinka T; Matsumoto I
    J Chromatogr; 1991 Jan; 562(1-2):139-45. PubMed ID: 2026687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute encephalopathy with hepatic steatosis induced by pantothenic acid antagonist, calcium hopantenate, in dogs.
    Noda S; Haratake J; Sasaki A; Ishii N; Umezaki H; Horie A
    Liver; 1991 Jun; 11(3):134-42. PubMed ID: 1886458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia.
    Kashihara K; Ebara T; Yamamoto M; Ogawa T; Harada T; Otsuki S
    Folia Psychiatr Neurol Jpn; 1985; 39(2):147-53. PubMed ID: 2866149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Reye's syndrome occurred during administration of calcium hopantenate].
    Shimizu S; Miura M; Kawaguchi T; Nakamura Y; Takei M; Miyahara H; Furuta K; Sodeyama T; Kiyosawa K; Furuta S
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2540-4. PubMed ID: 2277444
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass spectrometric identification of 2-hydroxydodecanedioic acid and its homologues in urine from patients with hopantenate therapy during clinical episode.
    Matsumoto M; Kuhara T; Inoue Y; Shinka T; Matsumoto I; Kajita M
    Biomed Environ Mass Spectrom; 1990 Mar; 19(3):171-5. PubMed ID: 2331533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delayed type malignant syndrome and Parkinson's syndrome due to tiapride, Reye-like syndrome induced by calcium hopantenate].
    Noda S
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):538-41. PubMed ID: 10434717
    [No Abstract]   [Full Text] [Related]  

  • 16. [Facilitatory effect of calcium hopantenate on amygdaloid kindling in rats].
    Suzuki S; Kaneko Y; Mori N; Hoshino S; Kumashiro H
    No To Shinkei; 1988 Jun; 40(6):581-4. PubMed ID: 3224034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium hopantenate on the hypothalamic-pituitary-thyroid axis in rats.
    Mitsuma T; Nogimori T
    Horm Res; 1983; 18(4):210-4. PubMed ID: 6416983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hopantenic acid beta-glucoside as a new urinary metabolite of calcium hopantenate in dogs.
    Nakano K; Ando H; Sugawara Y; Ohashi M; Harigaya S
    Drug Metab Dispos; 1986; 14(6):740-5. PubMed ID: 2877836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iatrogenic diseases in the elderly].
    Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 1991 Jul; 28(4):493-8. PubMed ID: 1942629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome].
    Medvedev VE; Epifanov AV; Zverev KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):42-8. PubMed ID: 22810740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.